Skip to main content
. Author manuscript; available in PMC: 2011 Jun 15.
Published in final edited form as: J Infect Dis. 2010 Jun 15;201(12):1788–1795. doi: 10.1086/652749

Table 2.

Median Levels and Interquartile Range (IQR) of Biomarkers for SMART, CARDIA and MESA Participants

Participants aged 33–44 years
Participants aged 45–76 years
SMART (N=287*)
CARDIA (N=3231)
% Diff. (P-value)
SMART (N=494§)
MESA (N=5386)
% Diff. (P-value)
Median
IQR
Median
IQR
Median
IQR
Median
IQR
hsCRP (μg/mL) 2.12 0.80–4.77 1.36 0.53–3.78 55.2 (<0.001) 2.68 1.07–6.01 2.17 0.94–4.70 49.6 (<0.001)
IL-6 (pg/mL) 2.09 1.26–3.49 1.29 0.80–2.07 62.1 (<0.001) 2.63 1.63–4.18 1.23 0.79–1.92 151.6 (<0.001)
D-dimer (μg/mL) 0.29 0.17–0.55 NA NA NA 0.34 0.20–0.61 0.20 0.13–0.35 94.3 (<0.001)
Cystatin C (mg/dl) 0.94 0.82–1.07 NA NA NA 1.00 0.88–1.17 0.85 0.76–0.96 27.2 (<0.001)

NA = not available

*

172 had cystatin C measurements.

689 had IL-6 measurements.

% difference in means of log transformed value, adjusted for age, race, gender, BMI, smoking, total/HDL cholesterol, diabetes, lipid-lowering therapy and blood pressure lowering therapy.

§

231 had cystatin C measurements.